(Q35191600)

English

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults

scientific article published on 20 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Nicholas P J Day

15

object named as

Nicholas P J Day

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Wirichada Pan-Ngum

10

object named as

Wirichada Pan-Ngum

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Nicholas John White

14

object named as

Nicholas J White

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Pratap Singhasivanon

object named as

Pratap Singhasivanon

13

0 references

Kasia Stepniewska

3

object named as

Kasia Stepniewska

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sasithon Pukrittayakamee

1

object named as

Sasithon Pukrittayakamee

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Warunee Hanpithakpong

9

object named as

Warunee Hanpithakpong

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Podjanee Jittamala

2

object named as

Podjanee Jittamala

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Salwaluk Panapipat

12

object named as

Salwaluk Panapipat

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

Niklas Lindegardh

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sunee Chueasuwanchai

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Wattana Leowattana

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Aphiradee Phakdeeraj

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sutatip Permpunpanich

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Caroline Fukuda

11

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

20 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

4050-4057

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Effect of half-life on the pharmacodynamic index of zanamivir against influenza virus delineated by a mathematical model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

28 July 2018

Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

28 July 2018

The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

28 July 2018

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

28 July 2018

Oseltamivir resistance during treatment of influenza A (H5N1) infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

28 July 2018

Oseltamivir resistance--disabling our influenza defenses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

28 July 2018

Avian influenza A (H5N1) infection in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

28 July 2018

The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

28 July 2018

The low potential for drug interactions with zanamivir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

28 July 2018

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

28 July 2018

Pharmacokinetics of high-dose oseltamivir in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

27 September 2018

Importance of collection tube during clinical studies of oseltamivir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

27 September 2018

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

27 September 2018

The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

27 September 2018

Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165358

27 September 2018

Identifiers

10.1128/AAC.00159-11

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35191600&oldid=2143706760"